T-HCA
Trans-4-Hydroxycrotonic acid (T-HCA) is a pharmacologically significant compound that has garnered attention in the field of scientific research due to its structural and functional relationship with Gamma-Hydroxybutyric Acid (GHB). Although closely related to GHB, T-HCA showcases unique binding characteristics and does not display the typical sedative effects associated with GHB. Additionally, evidence suggests that T-HCA might be endogenously produced in the mammalian central nervous system, raising the hypothesis that it could function as a natural ligand for the GHB receptor.
Chemical Properties and Relationship to GHB[edit | edit source]
Structural Kinship: T-HCA is structurally akin to GHB, a compound known for its sedative and euphoric effects. Binding Affinity: Despite its structural resemblance, T-HCA exhibits a 4-fold higher binding affinity to the GHB receptor than GHB itself[1].
Pharmacological Actions[edit | edit source]
- Non-Sedative: Contrary to GHB, T-HCA does not activate the primary sedative target, the GABAB receptor. As such, it doesn't elicit the sedative responses commonly seen with GHB.
- Convulsive Effects: T-HCA has been documented to induce convulsions, a phenomenon believed to be a consequence of heightened glutamate release.
- Potential Endogenous Role: Given the notion that T-HCA might be naturally synthesized in the mammalian central nervous system, it's speculated to serve as an endogenous ligand for the GHB receptor.
Therapeutic Implications and Research Applications[edit | edit source]
- Neurological Insights: The ability of T-HCA to induce convulsions offers a potential model for studying seizure mechanisms and exploring therapeutic interventions.
- Endogenous Function: Establishing T-HCA as a naturally occurring ligand in the central nervous system might pave the way for understanding novel neuromodulatory processes.
- GHB Receptor Function: T-HCA's differential binding and functional characteristics, in comparison to GHB, can elucidate the broader roles and functions of the GHB receptor in neural systems.
Conclusion[edit | edit source]
Trans-4-Hydroxycrotonic acid provides a compelling avenue for investigating the complex interactions within the GABAergic system and its associated receptors. Its unique pharmacological profile and potential endogenous role in the mammalian central nervous system position T-HCA as a molecule of great interest in neuropharmacological research.
References[edit | edit source]
- Benavides, J., et al. (1982). Specific GHB-binding sites in rat and human brain. Biochemical Pharmacology, 31(13), 2161-2164.
See also[edit | edit source]
- ↑ Benavides, J., et al. (1982). Specific GHB-binding sites in rat and human brain. Biochemical Pharmacology, 31(13), 2161-2164.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD